Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03284385
Title Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

Advanced Solid Tumor

clear cell renal cell carcinoma

Therapies

Adavosertib

Age Groups:
Covered Countries USA


No variant requirements are available.